Schonfeld Strategic Advisors’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-24,193
| Closed | -$1.14M | – | 1981 |
|
|
2024
Q3 | $1.14M | Buy |
+24,193
| New | +$1.14M | 0.01% | 991 |
|
|
2024
Q1 | – | Sell |
-17,228
| Closed | -$1.08M | – | 1928 |
|
|
2023
Q4 | $1.08M | Buy |
+17,228
| New | +$1.08M | 0.01% | 938 |
|
|
2022
Q4 | – | Sell |
-17,567
| Closed | -$1.15M | – | 2571 |
|
|
2022
Q3 | $1.15M | Buy |
+17,567
| New | +$1.15M | 0.01% | 1163 |
|
|
2021
Q3 | – | Sell |
-10,271
| Closed | -$1.66M | – | 2042 |
|
|
2021
Q2 | $1.66M | Buy |
+10,271
| New | +$1.66M | 0.02% | 738 |
|
|
2020
Q2 | – | Sell |
-8,600
| Closed | -$365K | – | 1246 |
|
|
2020
Q1 | $365K | Buy |
+8,600
| New | +$365K | 0.02% | 681 |
|
|
2019
Q4 | – | Sell |
-26,420
| Closed | -$1.08M | – | 1289 |
|
|
2019
Q3 | $1.08M | Buy |
+26,420
| New | +$1.08M | 0.03% | 452 |
|
|
2018
Q4 | – | Sell |
-13,700
| Closed | -$607K | – | 1084 |
|
|
2018
Q3 | $607K | Buy |
+13,700
| New | +$607K | 0.03% | 538 |
|